Lenvima

Doubling down on the Keytruda franchise, Merck pays $300M and promises $5B-plus to partner with Eisai on its budding cancer star
Doubling down on the Keytruda franchise, Merck pays $300M and promises $5B-plus to partner with Eisai on its budding cancer star
Endpoints
Merck
Keytruda
Eisai
Lenvima
Flag link:
Merck & Co. and Eisai seek to undermine BMS’ position in kidney cancer treatment sector
Merck & Co. and Eisai seek to undermine BMS’ position in kidney cancer treatment sector
GoinPharma
Eisai
Merck
Bristol-Myers Squibb
kidney cancer
Keytruda
Lenvima
Opdivo
Flag link:
Merck, Eisai nab Keytruda-Lenvima 'breakthrough' in quickly crowding kidney cancer field
Merck, Eisai nab Keytruda-Lenvima 'breakthrough' in quickly crowding kidney cancer field
Fierce Pharma
Merck
Eisai
Keytruda
Lenvima
kidney cancer
Flag link:
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Fierce Pharma
Eisai
Lenvima
liver cancer
Bayer
Nexavar
ASCO 2017
Flag link:
Eisai's kidney drug wins expanded indication in the U.S.
Eisai's kidney drug wins expanded indication in the U.S.
BioPharma Dive
Eisai
advanced renal cell carcinoma
kidney cancer
Lenvima
RCC
Flag link:
Eisai scores FDA priority review for bigger Lenvima use in kidney cancer
Eisai scores FDA priority review for bigger Lenvima use in kidney cancer
Fierce Pharma
Eisai
Lenvima
kidney cancer
FDA
priority review
Flag link:
Eisai's launch for 'crown jewel' Lenvima tracking better than execs expected
Eisai's launch for 'crown jewel' Lenvima tracking better than execs expected
Fierce Pharma Marketing
Eisai
Lenvima
thyroid cancer
Flag link:
Eisai Says New Cancer Drug Reaching Patients Faster Than Planned
Eisai Says New Cancer Drug Reaching Patients Faster Than Planned
Bloomberg
Eisai
patients
Lenvima
thyroid cancer
Flag link:
Eisai gets EMA nod for Lenvima just weeks after FDA approval
Eisai gets EMA nod for Lenvima just weeks after FDA approval
Fierce Pharma
Eisai
FDA
Lenvima
thyroid cancer
Flag link:
Can Eisai pump its thyroid cancer pill to $1B in sales? Rival Bayer might object
Can Eisai pump its thyroid cancer pill to $1B in sales? Rival Bayer might object
Fierce Pharma Marketing
Eisai
Bayer
thyroid cancer
Lenvima
Nexavar
Flag link:
FDA approves Eisai's thyroid cancer drug
FDA approves Eisai's thyroid cancer drug
Yahoo/Reuters
Eisai
thyroid cancer
FDA
Lenvima
Flag link: